Features Archives - Page 9 of 15

Features

KPMG becomes BaseLaunch partner

The healthcare accelerator program BaseLaunch from BaselArea.swiss, supports startups from the healthcare sector. In addition to prominent pharmaceutical companies, it can now count the consultancy firm KPMG as one of…

clement20.11.2017

Features

Novartis presents current state of research

Novartis presented recent developments in its research programme to investors in London, including positive results for its ophthalmology treatment RTH258.

clement13.11.2017

Features

Myovant Sciences Announces Positive Top-line Results from Takeda’s Phase 3 Study Evaluating the Efficacy and Safety of Relugolix for the Treatment of Pain Associated with Uterine Fibroids

clement10.11.2017

Features

NousCom wins over investors

NousCom, a Basel-based oncology company, raised 42 million euros in a Series B financing round. It will use the new funds to drive development of…

clement07.11.2017

Features

Novartis, Amgen and Banner aim for Alzheimer’s prevention with new BACE trials

clement03.11.2017

Features

Novartis to strengthen oncology portfolio with new acquisition

The Basel-based pharmaceutical company Novartis has entered into a memorandum of understanding to acquire Advanced Accelerator Applications, a French radiopharmaceutical company that specializes in nuclear…

clement30.10.2017

Features

Roivant enters into partnership with AstraZeneca

Basel – The pharmaceutical company Roivant Sciences will develop a drug for AstraZeneca, marking the first time the two companies will work together.

clement23.10.2017

Features

Roche invests in novel antibiotics

The Basel-based pharmaceutical company Roche is collaborating with the U.S. biotechnology firm Warp Drive Bio, which developed a proprietary technology platform to discover and develop…

clement17.10.2017

Features

“You should always have something crazy cooking on the back burner”

When Jennifer Doudna gave her keynote at Basel Life in September, the auditorium in the Congress Center was packed. Susan Gasser, Professor of Molecular Biology at…

clement17.10.2017

Features

Myovant therapy effective against uterine fibroids

The Basel-based pharmaceutical company Myovant Sciences has published positive study results for its therapy relugolix, which has now been shown to be effective and safe…

clement03.10.2017

Features

KPMG becomes BaseLaunch partner

Novartis presents current state of research

Myovant Sciences Announces Positive Top-line Results from Takeda’s Phase 3 Study Evaluating the Efficacy and Safety of Relugolix for the Treatment of Pain Associated with Uterine Fibroids

NousCom wins over investors

Novartis, Amgen and Banner aim for Alzheimer’s prevention with new BACE trials

Novartis to strengthen oncology portfolio with new acquisition

Roivant enters into partnership with AstraZeneca

Roche invests in novel antibiotics

“You should always have something crazy cooking on the back burner”

Myovant therapy effective against uterine fibroids

Useful links

Contact us

Sign up for our newsletter and event invitations

Follow us